Related references
Note: Only part of the references are listed.Predictive Parameters of Febrile Neutropenia and Clinical Significance of G-CSF Receptor Signaling Pathway in the Development of Neutropenia during R-CHOP Chemotherapy with Prophylactic Pegfilgrastim in Patients with Diffuse Large B-Cell Lymphoma
Do Young Kim et al.
CANCER RESEARCH AND TREATMENT (2022)
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
Ahuva Averin et al.
SUPPORTIVE CARE IN CANCER (2021)
Impact of cancer cell-intrinsic features on neutrophil behavior
Danique E. M. Duits et al.
SEMINARS IN IMMUNOLOGY (2021)
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)
Juan C. Ramos et al.
BLOOD (2020)
Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
Weiping Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial
A. Kuhnl et al.
ANNALS OF ONCOLOGY (2017)
BMX Negatively Regulates BAK Function, Thereby Increasing Apoptotic Resistance to Chemotherapeutic Drugs
Joanna L. Fox et al.
CANCER RESEARCH (2015)
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials
Li Wang et al.
SUPPORTIVE CARE IN CANCER (2015)
Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review
Gary H. Lyman et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Therapeutic Targeting of the Cyclin D3:CDK4/6 Complex in T Cell Leukemia
Catherine M. Sawai et al.
CANCER CELL (2012)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
Receiver Operating Characteristic (ROC) Curve for Medical Researchers
Rajeev Kumar et al.
INDIAN PEDIATRICS (2011)
Doxorubicin pathways: pharmacodynamics and adverse effects
Caroline F. Thorn et al.
PHARMACOGENETICS AND GENOMICS (2011)
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Jonathan W. Friedberg
HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM (2011)
DEGseq: an R package for identifying differentially expressed genes from RNA-seq data
Likun Wang et al.
BIOINFORMATICS (2010)
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project
Milena Sant et al.
BLOOD (2010)
Doxorubicin: The Good, the Bad and the Ugly Effect
Cristina Carvalho et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Ali Mortazavi et al.
NATURE METHODS (2008)
Bnip3 mediates mitochondrial dysfunction and cell death through Bax and Bak
Dieter A. Kubl et al.
BIOCHEMICAL JOURNAL (2007)
Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: A systematic review
Nicole M. Kuderer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
Thomas M. Habermann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients
NM Kuderer et al.
CANCER (2006)
Medication safety in the ambulatory chemotherapy setting
TK Gandhi et al.
CANCER (2005)
Risk models for predicting chemotherapy-induced neutropenia
GH Lyman et al.
ONCOLOGIST (2005)
Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy
V Caggiano et al.
CANCER (2005)
Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17
MA Stark et al.
IMMUNITY (2005)
Chemotherapy-induced neutropenia - Risks, consequences, and new directions for its management
J Crawford et al.
CANCER (2004)
BCCIP Functions through p53 to regulate the expression of p21Waf1/Cip1
XB Meng et al.
CELL CYCLE (2004)
Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy
GH Lyman et al.
LEUKEMIA & LYMPHOMA (2003)
Neurotoxic complications of chemotherapy in patients with cancer - Clinical signs and optimal management
CCP Verstappen et al.
DRUGS (2003)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)